Grove Collaborative Holdings, Inc. (GROV): Nasdaq/NYSE listing notice — Grove receives NYSE notice of non-compliance with $1.00 minimum share price; 6-month cure

Grove Collaborative Holdings, Inc.

Average closing price below $1.00 over 30 consecutive trading days triggered NYSE notice on Dec. 14, 2022.
Company has six months from Notice receipt to regain compliance by closing price >=$1.00 and 30-day avg >=$1.00.
Common stock remains listed on NYSE (symbol GROV) with added ".BC" designation indicating non-compliance.
No immediate impact on business operations, SEC reporting, or debt obligations; failure to cure could lead to delisting.
Company plans to notify NYSE of intent to cure within 10 business days.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Grove Collaborative Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

December 14, 2022, Grove Collaborative Holdings, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the average per share trading price of its common stock (the “Common Stock”) was below the NYSE’s continued listing standard rule relating to minimum average share price. Rule 802.01C of the NYSE’s Listed Company Manual requires that a company’s common stock trade at a minimum average closing price of $1.00 over a consecutive 30 trading-day period. Pursuant to Section 802.01C, the Company has a period of six months following the receipt of the

View on SEC.gov

Browse all listing & compliance notices →

Grove Collaborative Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001841761-22-000079

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.